Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Vimta Labs Ltd.

Vimta Labs

NSE

0.00

0.00 (0.00)%

Healthcare

Small-cap

With a market cap of ₹18.90L Cr.

Moderate Volatility
Stock is 1.13x as volatile as index
To access realtime data for Reliance Industries Ltd, and use advance features for trading Register or Login to Orca.

Subsidiaries

No Data Available

No Subsidiaries Data available

Management

1. Sivalinga Prasad Vasireddi
Chairman
2. Harita Vasireddi
Managing Director
3. Harriman Vungal
Executive Director - Operations
4. Satya Sreenivas Neerukonda
Executive Director
5. Sanjay Dave
Non Executive Independent Director
6. Yadagiri R Pendri
Non Executive Independent Director
7. Sujani Vasireddi
Company Secretary & Compliance Officer
8. Yalamanchili Prameela Rani
Non Executive Independent Director
9. G Purnachandra Rao
Non Executive Independent Director

Contact Information

Company Address

Plot Nos 141/2 & 142, I D A Phase I I, Cherlapally, R R District
Hyderabad, Telangana - 500051
www.vimta.com
shares@vimta.com

Registrar

Cil Securities Ltd
214 Raghava Ratna Towers , Chirag Ali Lane,Abidas,Hyderabad
Phone: 040-3203155/149
Email:
Website:

Company Profile

Vimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta assists the food industry commissions for nutritional labelling, food safety evaluations, trace analysis and shelf life studies.

Vimta has a team of 684 professionals comprising 446 scientists in various disciplines such as chemistry, pharma, medicine, microbiology, molecular biology and informatics. The team is slated to double in next three years.

Vimta is a multi-site organization with more than 300,000 sqft world class laboratory facilities. The technologies deployed at Vimta are current and leading edge, duly validated.

Vimta has over 12 years of experience in providing preclinical services to Pharma companies world-wide accordance with the guidelines prescribed by international agencies.

Vimta has a state-of-art building of Class 10,000 Pre-clinical facility with a total built up area of 33,000 sq.ft. with 32 rodent experimental rooms, 5 procedure rooms, separate quarantine facility and distinct non-rodent facility with 48 SS kennels with a comfortable perch, liberal exercise area.

It provides services in pharmacology, toxicology and DMPK areas. The toxicology services include but not limited to in-vivo and in-vitro genotoxicity, acute to chronic toxicity, carcinogenicity, reproductive toxicity studies, safety pharmacology, and immunotoxicology. Pharmacology services are available in various therapeutics areas such as pain & inflammation, metabolic disorders, respiratory, CNS, and xenograft & allograft models for oncology. In addition to the regulatory studies we use tailor-made in vitro and in vivo ADME techniques to help profile your drug candidate in both rodent and non-rodent animals models.

Services offered by the company:

  • Advanced Molecular Biology
  • Food and Agriculture
  • Drugs & Pharma
  • Water
  • Environmental Assessments
  • Clinical Research
  • Clinical Reference Lab Services
  • Preclinical Research
  • Genomics Online Ordering

 Achievements/ recognition

  •    NABL as per ISO 15189:2007
Enrich money logo